Newton J F, Yoshimoto M, Bernstein J, Rush G F, Hook J B
Toxicol Appl Pharmacol. 1983 Jun 30;69(2):291-306. doi: 10.1016/0041-008x(83)90311-3.
Acetaminophen (APAP) produced renal necrosis restricted to the straight segment of the proximal tubule in Fischer 344 (F344) rats but not in Sprague-Dawley (SD) rats. APAP-induced renal functional changes (elevation in blood urea nitrogen and reduction in the accumulation of p-aminohippurate by renal cortical slices) also correlated with strain-dependent histopathological changes. Such strain differences have been attributed to differences in renal P-450 activation of APAP or the deacetylation of APAP to the nephrotoxic metabolite, p-aminophenol (PAP). Kidneys from F344 rats displayed greater concentrations of P-450 and greater ethoxycoumarin-o-deethylase activity than kidneys from SD rats. However, covalent binding of [ring-14C]APAP to renal and hepatic microsomal protein in vitro was similar for both SD and F344 rats. Deacetylation of APAP to PAP was similar in renal and hepatic homogenates from SD and F344 rats. Furthermore, isolated kidneys from SD and F344 rats perfused with APAP excreted PAP at similar rates. PAP excretion, over a 24-hr period following APAP administration, was greater in F344 rats than in SD rats only at the highest dose (900 mg/kg) of APAP. Thus, strain differences in APAP-induced nephrotoxicity apparently cannot be attributed to differences in P-450 activation of APAP or in deacetylation to the nephrotoxic metabolite, PAP.
对乙酰氨基酚(APAP)在Fischer 344(F344)大鼠中导致肾坏死,且坏死局限于近端小管的直段,但在Sprague-Dawley(SD)大鼠中则不会。APAP诱导的肾功能变化(血尿素氮升高以及肾皮质切片对对氨基马尿酸盐积累的减少)也与品系依赖性组织病理学变化相关。这种品系差异归因于APAP的肾P-450激活或APAP脱乙酰化为肾毒性代谢物对氨基酚(PAP)的差异。F344大鼠的肾脏比SD大鼠的肾脏显示出更高浓度的P-450和更高的乙氧香豆素-O-脱乙基酶活性。然而,在体外,[环-14C]APAP与肾和肝微粒体蛋白的共价结合在SD和F344大鼠中相似。APAP脱乙酰化为PAP在SD和F344大鼠的肾和肝匀浆中相似。此外,用APAP灌注的SD和F344大鼠的离体肾脏以相似的速率排泄PAP。仅在最高剂量(900 mg/kg)的APAP给药后24小时内,F344大鼠的PAP排泄量比SD大鼠的大。因此,APAP诱导的肾毒性中的品系差异显然不能归因于APAP的P-450激活或脱乙酰化为肾毒性代谢物PAP的差异。